3-n-butylphthalide has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Malik, TH; Tan, SW; Xie, T | 1 |
| Jia, W; Sun, X; Zhang, T | 1 |
1 review(s) available for 3-n-butylphthalide and Diabetes Mellitus
| Article | Year |
|---|---|
Advances of neurovascular protective potential of 3-N-butylphthalide and its derivatives in diabetic related diseases.
Topics: Benzofurans; Diabetes Complications; Diabetes Mellitus; Humans; Oxidative Stress | 2022 |
1 other study(ies) available for 3-n-butylphthalide and Diabetes Mellitus
| Article | Year |
|---|---|
3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats.
Topics: Animals; Apoptosis; Benzofurans; Cerebral Arteries; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Gliosis; Hippocampus; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Up-Regulation; Vascular Endothelial Growth Factor A | 2010 |